Summary
The FDA has approved leucovorin, a type of vitamin B, for treating autism in children. Concerns about Dr. Mehmet Oz potentially profiting from this approval have been addressed, with the Health and Human Services Department stating that he will not benefit due to the focus on prescription drugs. Dr. Oz has pledged to divest his shares in a company selling folinic acid, the supplement found in leucovorin.
Key Facts
- The FDA approved leucovorin, a form of folinic acid, to treat autism in children.
- Leucovorin is believed to help due to its role in folate transportation, crucial for healthy blood cells.
- Dr. Mehmet Oz has investments in iHerb, a company selling folinic acid.
- HHS clarified that the approval covers only prescription leucovorin, not over-the-counter versions.
- Dr. Oz pledged to sell his shares in iHerb, but it's unclear if he has sold all his shares.
- The Autism Science Foundation stated that research on leucovorin and autism is at an early stage.
- HHS emphasized the difference between prescription drugs and over-the-counter supplements.
